Ignite Creation Date:
2024-05-06 @ 8:56 AM
Last Modification Date:
2024-10-26 @ 12:07 PM
Study NCT ID:
NCT02864914
Status:
COMPLETED
Last Update Posted:
2022-08-03
First Post:
2016-05-13
Brief Title:
Post-authorisation Safety Study in Patients With Type 2 Diabetes to Assess the Risk of Liver Injury Kidney Injury Urinary Tract and Genital Infections and Diabetic Ketoacidosis in Patients Treated With Empagliflozin Compared to DPP-4 Inhibitors
Sponsor:
Boehringer Ingelheim
Organization:
Boehringer Ingelheim
Organization Data
Organization:
Boehringer Ingelheim
Class:
INDUSTRY
Study ID:
124596
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Boehringer Ingelheim
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Eli Lilly and Company | INDUSTRY |